The global nasal drug delivery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth.
Browse the full report description of “Global Nasal Drug Delivery Market Size, Share & Trends Analysis Report by Dosage Form (Gels, Sprays, Drops and Liquids, and Others), by Containers (Non-Pressurized Containers, and Pressurized Containers), by Therapeutic Application (Rhinitis, Nasal Congestion, Asthma, and Others) and by End-User (Hospitals, and Home Health Care) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/nasal-drug-delivery-market
Hence owing to the development and manufacturing of innovative solutions the nasal drug delivery market is augmenting its growth over the forecast period. For instance,
• In May 2022, Birmingham Biotech Ltd. launched BHM Anti-Viral Nasal Spray to help prevent infection from the inhalation of airborne viruses. This spray is easy to use the nasal device with a patented formulation, Norizite, It was developed by the Healthcare Technologies Institute at the University of Birmingham.
• In April 2022, Upperton Pharma Solutions launched a nasal delivery development platform named as UpperNose, to access the necessary capabilities for the development of nasal dosage formulations. In this platform, timely develops molecules n both liquid and dry powder nasal formulations.
• In December 2021, Orexo had gone into partnership with many companies, to improve adrenaline auto-injectors such as EpiPen and it also developed OX640, a platform for creating particles that combine the drug with carrier materials and it enables nasal delivery. The company has also applied amorphOX drug delivery platform that results in nasal adrenaline candidates.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Dosage Form
o By Containers
o By Therapeutics Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- 3M Co., APTARGROUP INC., AstraZeneca, Becton Dickinson and Co., Johnson & Johnson Service Inc., Merck KGaA, Novartis International AG,
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Nasal Drug Delivery Market Report Segment
By Dosage Form
By Containers
By Therapeutic Applications
By End User
Global Nasal Drug Delivery Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/nasal-drug-delivery-market